Realtime AI News
OncoAgent: A Guideline-Aware AI Agent That Auto-Delineates Radiotherapy Targets Without Retraining
A new arXiv paper introduces OncoAgent, an AI agent framework that reads textual clinical guidelines and auto-delineates radiotherapy target volumes without requiring costly retraining.
A research paper published on arXiv (ID: 2603.09448) introduces OncoAgent, a novel guideline-aware AI agent framework for zero-shot clinical target volume (CTV) auto-delineation in radiotherapy. CTV delineation involves complex margin definitions constrained by tumor location and anatomical barriers, making it one of the most challenging tasks in radiation oncology.
Traditional deep learning models can automate this process, but they rely rigidly on expert-annotated data, requiring costly retraining whenever clinical guidelines are updated. OncoAgent overcomes this limitation by seamlessly converting textual clinical guidelines into actionable AI instructions without retraining.
This means that when radiotherapy guidelines change — which happens periodically as medical evidence evolves — OncoAgent can directly read the new guideline text and adjust its delineation behavior, dramatically reducing maintenance costs. The paper was published with a "replace-cross" announcement type, indicating cross-disciplinary revisions.
OncoAgent represents an important trend in healthcare AI: moving from static "train once, freeze forever" models toward dynamic AI agents that understand documents and adapt autonomously. This paradigm shift is especially significant for clinical environments where guidelines are frequently updated based on emerging medical evidence.
Why it matters
OncoAgent introduces a new paradigm for medical AI — guideline-aware agents that adapt to document changes without retraining — potentially reducing maintenance costs and accelerating clinical deployment.